Performance of Ga-68 PSMA PET/CT for diagnosis and grading of local prostate cancer

Background: We aimed to evaluate the utility of prostate-specific membrane antigen (PSMA) PET/CT for the detection of local disease within the prostate. Methods: This is a retrospective review of a single-center experience evaluating intraprostatic detection rates compared with final histopathology...

Full description

Bibliographic Details
Main Authors: Timothy N. Kwan, Sandra Spremo, Amy Y.M. Teh, David McHarg, Isaac Thangasamy, Henry H. Woo
Format: Article
Language:English
Published: Elsevier 2021-06-01
Series:Prostate International
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2287888220300544
_version_ 1797714965725970432
author Timothy N. Kwan
Sandra Spremo
Amy Y.M. Teh
David McHarg
Isaac Thangasamy
Henry H. Woo
author_facet Timothy N. Kwan
Sandra Spremo
Amy Y.M. Teh
David McHarg
Isaac Thangasamy
Henry H. Woo
author_sort Timothy N. Kwan
collection DOAJ
description Background: We aimed to evaluate the utility of prostate-specific membrane antigen (PSMA) PET/CT for the detection of local disease within the prostate. Methods: This is a retrospective review of a single-center experience evaluating intraprostatic detection rates compared with final histopathology in a radical prostatectomy (RP) population. Seventy-two patients had PSMA PET/CT scan performed as part of their primary staging. Intraprostatic PSMA PET/CT avidity was assessed. PSMA PET/CT uptake was retrospectively correlated with patient characteristics including final histopathology, MRI Prostate Imaging Reporting and Data System (PI-RADS) score, clinical tumor stage, prostate-specific antigen (PSA) level, and patient age. Results: The sensitivity of PSMA PET/CT for the detection of RP-confirmed prostate cancer was 81.2%. Much higher sensitivity was found within certain subpopulations. The patient characteristics that most strongly correlated with focal intraprostatic PSMA PET/CT uptake were patient age (Kendall's tau coefficient τb = 0.24, p < 0.05) and clinical T stage (τb = 0.21, p < 0.05).The International Society of Urological Pathology (ISUP) grade group from final RP was predicted by standardized uptake value (SUVmax) and to a lesser extent PSA and the maximal dimension of PET-avid lesions. SUVmax monotonically increased with ISUP grade group. If SUVmax was above 10 g/mL, the final RP histopathology had a relative risk of 2.3 (95% CI 1.3–4.1) of being ISUP grade group 5. Conclusion: This trial provides early evidence that PSMA PET/CT assists in the grading of prostate cancer and suggests that the imaging modality is particularly accurate in subpopulations including the elderly and those with palpable disease.
first_indexed 2024-03-12T07:59:48Z
format Article
id doaj.art-59ed53b02261496e9f02858b397a032f
institution Directory Open Access Journal
issn 2287-8882
language English
last_indexed 2024-03-12T07:59:48Z
publishDate 2021-06-01
publisher Elsevier
record_format Article
series Prostate International
spelling doaj.art-59ed53b02261496e9f02858b397a032f2023-09-02T19:55:17ZengElsevierProstate International2287-88822021-06-0192107112Performance of Ga-68 PSMA PET/CT for diagnosis and grading of local prostate cancerTimothy N. Kwan0Sandra Spremo1Amy Y.M. Teh2David McHarg3Isaac Thangasamy4Henry H. Woo5University of Sydney, AustraliaUniversity of Sydney, AustraliaUniversity of Sydney, AustraliaNorthern Nuclear Medicine, AustraliaFaculty of Medicine, University of Queensland, Brisbane, Queensland, AustraliaUniversity of Sydney, Australia; Corresponding author. San Clinic, Suite 406, 185 Fox Valley Road, Wahroonga, Australia.Background: We aimed to evaluate the utility of prostate-specific membrane antigen (PSMA) PET/CT for the detection of local disease within the prostate. Methods: This is a retrospective review of a single-center experience evaluating intraprostatic detection rates compared with final histopathology in a radical prostatectomy (RP) population. Seventy-two patients had PSMA PET/CT scan performed as part of their primary staging. Intraprostatic PSMA PET/CT avidity was assessed. PSMA PET/CT uptake was retrospectively correlated with patient characteristics including final histopathology, MRI Prostate Imaging Reporting and Data System (PI-RADS) score, clinical tumor stage, prostate-specific antigen (PSA) level, and patient age. Results: The sensitivity of PSMA PET/CT for the detection of RP-confirmed prostate cancer was 81.2%. Much higher sensitivity was found within certain subpopulations. The patient characteristics that most strongly correlated with focal intraprostatic PSMA PET/CT uptake were patient age (Kendall's tau coefficient τb = 0.24, p < 0.05) and clinical T stage (τb = 0.21, p < 0.05).The International Society of Urological Pathology (ISUP) grade group from final RP was predicted by standardized uptake value (SUVmax) and to a lesser extent PSA and the maximal dimension of PET-avid lesions. SUVmax monotonically increased with ISUP grade group. If SUVmax was above 10 g/mL, the final RP histopathology had a relative risk of 2.3 (95% CI 1.3–4.1) of being ISUP grade group 5. Conclusion: This trial provides early evidence that PSMA PET/CT assists in the grading of prostate cancer and suggests that the imaging modality is particularly accurate in subpopulations including the elderly and those with palpable disease.http://www.sciencedirect.com/science/article/pii/S2287888220300544Prostatic neoplasmsPositron-emission tomographyObservational study
spellingShingle Timothy N. Kwan
Sandra Spremo
Amy Y.M. Teh
David McHarg
Isaac Thangasamy
Henry H. Woo
Performance of Ga-68 PSMA PET/CT for diagnosis and grading of local prostate cancer
Prostate International
Prostatic neoplasms
Positron-emission tomography
Observational study
title Performance of Ga-68 PSMA PET/CT for diagnosis and grading of local prostate cancer
title_full Performance of Ga-68 PSMA PET/CT for diagnosis and grading of local prostate cancer
title_fullStr Performance of Ga-68 PSMA PET/CT for diagnosis and grading of local prostate cancer
title_full_unstemmed Performance of Ga-68 PSMA PET/CT for diagnosis and grading of local prostate cancer
title_short Performance of Ga-68 PSMA PET/CT for diagnosis and grading of local prostate cancer
title_sort performance of ga 68 psma pet ct for diagnosis and grading of local prostate cancer
topic Prostatic neoplasms
Positron-emission tomography
Observational study
url http://www.sciencedirect.com/science/article/pii/S2287888220300544
work_keys_str_mv AT timothynkwan performanceofga68psmapetctfordiagnosisandgradingoflocalprostatecancer
AT sandraspremo performanceofga68psmapetctfordiagnosisandgradingoflocalprostatecancer
AT amyymteh performanceofga68psmapetctfordiagnosisandgradingoflocalprostatecancer
AT davidmcharg performanceofga68psmapetctfordiagnosisandgradingoflocalprostatecancer
AT isaacthangasamy performanceofga68psmapetctfordiagnosisandgradingoflocalprostatecancer
AT henryhwoo performanceofga68psmapetctfordiagnosisandgradingoflocalprostatecancer